Kathy Mann
Papers
1
Total Citations
47
H-Index
1
About
Kathy Mann is a leading figure in clinical cytogenetics, whose work has fundamentally reshaped how genomic imbalances are diagnosed in postnatal care. Her primary research focuses on the validation and clinical implementation of array comparative genomic hybridisation (CGH) as a superior diagnostic tool. Mann’s most cited work, a 2010 study with 47 citations, provided critical evidence that array CGH could reliably replace traditional G-banded karyotyping as a first-line test for detecting genome-wide imbalances. This landmark contribution demonstrated a substantial increase in diagnostic yield for patients, offering a more sensitive and comprehensive analysis than conventional methods. By spearheading the transition from karyotyping to microarray technology, Mann directly improved the detection rate of pathogenic copy number variants, thereby enhancing diagnostic accuracy for individuals with developmental delay, congenital anomalies, and other genetic conditions. Her rigorous validation studies and implementation protocols have set a new standard in clinical genetics, making high-resolution genomic screening a routine part of patient care. Through this pivotal work, Kathy Mann has left an enduring impact on the field, streamlining diagnostics and improving outcomes for countless patients.
Research Focus
Key Achievements
Top Papers
- 1